Mei-Sze Chua

Asian Liver Center, Stanford University School of Medicine

Affiliated withStanford University School of Medicine

Research Area

Biography

Mei-Sze Chua has not added Biography.
If you are Mei-Sze Chua and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 11	2022

Other Publications

Article	Year
Molecular profiling of anemia in acute renal allograft rejection using DNA microarrays. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons\| PubMed ID: 12492705	2003
Increased expression of cytotoxic effector molecules: different interpretations for steroid-based and steroid-free immunosuppression. Pediatric transplantation\| PubMed ID: 12581329	2003
Microarrays: new tools for transplantation research. Pediatric nephrology (Berlin, Germany)\| PubMed ID: 12700956	2003
Applications of microarrays to renal transplantation: progress and possibilities. Frontiers in bioscience : a journal and virtual library\| PubMed ID: 12957854	2003
Gallium maltolate is a promising chemotherapeutic agent for the treatment of hepatocellular carcinoma. Anticancer research\| PubMed ID: 16827101	2006
Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc\| PubMed ID: 17170744	2007
N-Myc down-regulated gene 1 mediates proliferation, invasion, and apoptosis of hepatocellular carcinoma cells. Cancer letters\| PubMed ID: 18207320	2008
Small interfering RNA targeting CDC25B inhibits liver tumor growth in vitro and in vivo. Molecular cancer\| PubMed ID: 18269767	2008
Antibody Arrays Identify Potential Diagnostic Markers of Hepatocellular Carcinoma. Biomarker insights\| PubMed ID: 19578489	2008
Small molecule antagonists of Tcf4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo. International journal of cancer\| PubMed ID: 19662654	2010
Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells. Molecular cancer\| PubMed ID: 19778454	2009
Rodent-specific hypoxia response elements enhance PAI-1 expression through HIF-1 or HIF-2 in mouse hepatoma cells. International journal of oncology\| PubMed ID: 21042733	2010
Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin. Molecular cancer\| PubMed ID: 21314951	2011
Suppression of glypican 3 inhibits growth of hepatocellular carcinoma cells through up-regulation of TGF-β2. Neoplasia (New York, N.Y.)\| PubMed ID: 21847365	2011
Assessment and comparison of magnetic nanoparticles as MRI contrast agents in a rodent model of human hepatocellular carcinoma. Contrast media & molecular imaging\| PubMed ID: 22649042	2012
Molecular imaging of hepatocellular carcinoma xenografts with epidermal growth factor receptor targeted affibody probes. BioMed research international\| PubMed ID: 23710458	2013
Suppressing N-Myc downstream regulated gene 1 reactivates senescence signaling and inhibits tumor growth in hepatocellular carcinoma. Carcinogenesis\| PubMed ID: 24302615	2014
Epigenetics in hepatocellular carcinoma: an update and future therapy perspectives. World journal of gastroenterology\| PubMed ID: 24574704	2014
Imaging of hepatocellular carcinoma patient-derived xenografts using ⁸⁹Zr-labeled anti-glypican-3 monoclonal antibody. Biomaterials\| PubMed ID: 24836949	2014
Novel celastrol derivatives inhibit the growth of hepatocellular carcinoma patient-derived xenografts. Oncotarget\| PubMed ID: 25051375	2014
Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells. Oncotarget\| PubMed ID: 26246473	2015
NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation. Oncotarget\| PubMed ID: 26359353	2015
Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signaling. Oncotarget\| PubMed ID: 26497681	2015
Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle ... Gastroenterology\| PubMed ID: 28284560	2017
5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages. Cell research\| PubMed ID: 28820176	2017
A transfer-RNA-derived small RNA regulates ribosome biogenesis. Nature\| PubMed ID: 29186115	2017
SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway. Cell death & disease\| PubMed ID: 31406106	2019
Correction: SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway. Cell death & disease\| PubMed ID: 31641102	2019
An Automated, Quantitative, and Multiplexed Assay Suitable for Point-of-Care Hepatitis B Virus Diagnostics. Scientific reports\| PubMed ID: 31666635	2019
High Inflammatory Factor Grading Predicts Poor Disease-Free Survival in AJCC Stage I-II Hepatocellular Carcinoma Patients After R0 Resection. Cancer management and research\| PubMed ID: 31908534	2019
An NIR-II/MR dual modal nanoprobe for liver cancer imaging. Nanoscale\| PubMed ID: 32428058	2020
Analysis of Infected Host Gene Expression Reveals Repurposed Drug Candidates and Time-Dependent Host Response Dynamics for COVID-19. bioRxiv : the preprint server for biology\| PubMed ID: 32511305	2020
NIR-II imaging of hepatocellular carcinoma based on a humanized anti-GPC3 antibody. RSC medicinal chemistry\| PubMed ID: 35224499	2022